Candidemia in children

References

• Marodi L, Johnston RB Jr. Invasive Candida species disease in infants and children: occurrence, risk factors, management, and innate host defense mechanisms. Curr Opin Pediatr 2007;19:693-7
   PubMed Web of Science ®Google Scholar
• Zaoutis TE, Argon J, Chu J, et al. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 2005;41:1232-9
   PubMed Web of Science ®Google Scholar
• Filioti J, Spiroglou K, Panteliadis CP, et al. Invasive candidiasis in pediatric intensive care patients: epidemiology, risk factors, management, and outcome. Intensive Care Med 2007;33:1272-83
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Seifert H, Tallent SM, et al. Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J 2003;22:686-91
   PubMed Web of Science ®Google Scholar
• MacDonald L, Baker C, Chenoweth C. Risk factors for candidemia in a children’s hospital. Clin Infect Dis 1998;26:642-5
   PubMed Web of Science ®Google Scholar
• Zaoutis T, Prasad P, Localio RA, et al. Risk factors for candidemia in the pediatric intensive care unit. Abstracts of the Society for Healthcare Epidemiology of America annual meeting, San Diego, CA [Abstract 503; platform presentation]. 2009
   Google Scholar
• Blyth CC, Chen SC, Slavin MA, et al. Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics 2009;123:1360-8
   PubMed Web of Science ®Google Scholar
• Singhi S, Rao DS, Chakrabarti A. Candida colonization and candidemia in a pediatric intensive care unit. Pediatr Crit Care Med 2008;9:91-5
   PubMed Web of Science ®Google Scholar
• Zaoutis TE, Greves HM, Lautenbach E, et al. Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J 2004;23:635-41
   PubMed Web of Science ®Google Scholar
• Celebi S, Hacimustafaoglu M, Ozdemir O, et al. Nosocomial candidaemia in children: results of a 9-year study. Mycoses 2008;51:248-57
   PubMed Web of Science ®Google Scholar
• Zaoutis TE, Coffin SE, Chu JH, et al. Risk factors for mortality in children with candidemia. Pediatr Infect Dis J 2005;24:736-9
   PubMed Web of Science ®Google Scholar
• Pasqualotto AC, de Moraes AB, Zanini RR, et al. Analysis of independent risk factors for death among pediatric patients with candidemia and a central venous catheter in place. Infect Control Hosp Epidemiol 2007;28:799-804
   PubMed Web of Science ®Google Scholar
• Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48:503-35
   PubMed Web of Science ®Google Scholar
• Benjamin DK Jr, Smith PB, Arrieta A, et al. Safety and pharmacokinetics of repeat-dose micafungin in young infants. Clin Pharmacol Ther 2010;87:93-9
   PubMed Web of Science ®Google Scholar
• VandenBussche HL, Van Loo DA. A clinical review of echinocandins in pediatric patients. Ann Pharmacother 2010;44:166-77
   PubMed Web of Science ®Google Scholar
• Ikeda F, Saika T, Sato Y, et al. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan. Med Mycol 2009;47:145-8
   PubMed Web of Science ®Google Scholar
• Kawaguchi C, Arai I, Yasuhara H, et al. Efficacy of micafungin in treating four premature infants with candidiasis. Pediatr Int 2009;51:220-4
   PubMed Web of Science ®Google Scholar
• Smith PB, Walsh TJ, Hope W, et al. Pharmacokinetics of an elevated dosage of micafungin in premature neonates. Ped Infect Dis J 2009;28:412-15
   PubMed Web of Science ®Google Scholar
• Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-54
   PubMed Web of Science ®Google Scholar
• Abelson JA, Moore T, Bruckner D, et al. Frequency of fungemia in hospitalized pediatric inpatients over 11 years at a tertiary care institution. Pediatrics 2005;116:61-7
   PubMed Web of Science ®Google Scholar
• Watson RS, Carcillo JA, Linde-Zwirble WT, et al. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003;167:695-701
   PubMed Web of Science ®Google Scholar
• Pappas PG, Rex JH, Lee J, et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 2003;37:634-43
   PubMed Web of Science ®Google Scholar
• Zaoutis TE, Foraker E, McGowan KL, et al. Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children’s hospitals. Diagn Microbiol Infect Dis 2005;52:295-8
   PubMed Web of Science ®Google Scholar
• Malani PN, Bradley SF, Little RS, et al. Trends in species causing fungaemia in a tertiary care medical centre over 12 years. Mycoses 2001;44:446-9
   PubMed Web of Science ®Google Scholar
• Fisher BT, Zaoutis TE. Treatment of invasive candidiasis in immunocompromised pediatric patients. Paediatr Drugs 2008;10:281-98
   PubMedGoogle Scholar
• Trofa D, Gacser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev 2008;21:606-25
   PubMed Web of Science ®Google Scholar
• Prasad PA, Coffin SE, Leckerman KH, et al. Pediatric antifungal utilization: new drugs, new trends. Pediatr Infect Dis J 2008;27:1083-8
   PubMed Web of Science ®Google Scholar
• Walsh TJ. Echinocandins—an advance in the primary treatment of invasive candidiasis. N Engl J Med 2002;347:2070-2
   PubMed Web of Science ®Google Scholar
• Steinbach WJ, Benjamin DK. New antifungal agents under development in children and neonates. Curr Opin Infect Dis 2005;18:484-9
   PubMed Web of Science ®Google Scholar
• Seibel NL, Schwartz C, Arrieta A, et al. Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients. Antimicrob Agents Chemother 2005;49:3317-24
   PubMed Web of Science ®Google Scholar
• Heresi GP, Gerstmann DR, Reed MD, et al. The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants. Pediatr Infect Dis J 2006;25:1110-5
   PubMed Web of Science ®Google Scholar
• Benjamin DK Jr, Driscoll T, Seibel NL, et al. Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections. Antimicrob Agents Chemother 2006;50:632-8
   PubMed Web of Science ®Google Scholar
• Smith PB, Walsh TJ, Hope W, et al. Pharmacokinetics of an elevated dosage of micafungin in premature neonates. Pediatr Infect Dis J 2009;28:412-5
   PubMed Web of Science ®Google Scholar